Literature DB >> 17209143

Potential medical and surgical complications of serotonergic antidepressant medications.

Karl J Looper1.   

Abstract

Serotonergic antidepressants are the most widely used group of antidepressant medications. Although generally considered to have a favorable adverse-effect profile, serotonergic antidepressants are associated with potentially dangerous medical complications, some of which have only recently become apparent to patients and clinicians. This article reviews the association of serotonergic antidepressants and the following medical complications: syndrome of inappropriate antidiuretic hormone secretion, bleeding, serotonin syndrome, serotonin-discontinuation syndrome, and adverse pregnancy and neonatal effects. Physicians need to remain aware of these potential medical complications and integrate this information into their clinical decision-making, informed-consent process, baseline assessment, and follow-up monitoring.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17209143     DOI: 10.1176/appi.psy.48.1.1

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  9 in total

Review 1.  Medically serious adverse effects of newer antidepressants.

Authors:  Rajnish Mago; Rajeev Mahajan; Michael E Thase
Journal:  Curr Psychiatry Rep       Date:  2008-06       Impact factor: 5.285

2.  Serotonin syndrome associated with tramadol.

Authors:  Junji Takeshita; Mark H Litzinger
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

Review 3.  A generalist's guide to treating patients with depression with an emphasis on using side effects to tailor antidepressant therapy.

Authors:  J Michael Bostwick
Journal:  Mayo Clin Proc       Date:  2010-04-29       Impact factor: 7.616

4.  Upper gastrointestinal bleeding in a patient receiving selective serotonin reuptake inhibitor.

Authors:  Shobana Athimulam; Naveen Sharma; Shahid A Khan
Journal:  BMJ Case Rep       Date:  2011-05-19

5.  Upper gastrointestinal bleeding in a patient with depression receiving selective serotonin reuptake inhibitor therapy.

Authors:  Deepak Kumar; Tanuj Saaraswat; S N Sengupta; Saurabh Mehrotra
Journal:  Indian J Pharmacol       Date:  2009-02       Impact factor: 1.200

6.  Maternal depressive symptoms, depression, and psychiatric medication use in relation to risk of preterm delivery.

Authors:  Amelia R Gavin; Claudia Holzman; Kristine Siefert; Yan Tian
Journal:  Womens Health Issues       Date:  2009 Sep-Oct

Review 7.  Systematic review of healthcare costs related to mental health conditions among cancer survivors.

Authors:  Jaya S Khushalani; Jin Qin; John Cyrus; Natasha Buchanan Lunsford; Sun Hee Rim; Xuesong Han; K Robin Yabroff; Donatus U Ekwueme
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2018-06-20       Impact factor: 2.217

Review 8.  Psychiatric disease as a risk factor in fast-track hip and knee replacement.

Authors:  Silas Hinsch Gylvin; Christoffer Calov Jørgensen; Anders Fink-Jensen; Henrik Kehlet
Journal:  Acta Orthop       Date:  2016-02-22       Impact factor: 3.717

9.  Cardiac dysfunction and prenatal exposure to venlafaxine.

Authors:  Ana R Araújo; Mónica Marçal; Madalena Tuna; Rui Anjos
Journal:  Clin Case Rep       Date:  2016-03-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.